$18.90
Today
as of Sep 4, 16:54 ET
Last 30 days
Recent Press Releases & News
Research Tools & Consumables Stocks Q2 Recap: Benchmarking Sotera Health Company (NASDAQ:SHC)
Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings?
Sotera Health Company’s Q2 Earnings Call: Our Top 5 Analyst Questions
Overview
52-week range
$13
$20
86% of range
Avg surprise (last 3)
+11.1%
Avg reaction (last 2)
+2.4%
50% positive
Latest IV / EM
119%
EM ±18.5% · $20 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.19 | — | — | — | — | financials |
| Tue May 5, 2026 | Mar/2026 | $0.14 | $0.15 | -6.7% | +16.7% | -0.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.17 | — | — | — | — | financials |
| Fri Aug 8, 2025 | Jun/2025 | $0.18 | $0.15 | +20.0% | — | — | earnings |
| Thu May 1, 2025 | Mar/2025 | $0.12 | $0.10 | +20.0% | — | +5.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.06 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.03 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.02 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.05 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.08 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $0.01 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $321M | $280M | — | $311M | $294M | $255M | — | $285M |
| Cost of revenue | $143M | $133M | — | $134M | $128M | $119M | — | $127M |
| Gross profit | $178M | $147M | — | $178M | $167M | $135M | — | $158M |
| Operating income | — | — | — | — | — | — | — | $81M |
| Net income | $54M | $27M | — | $48M | $8M | $-13M | — | $17M |
| EPS (diluted) | $0.19 | $0.09 | — | $0.17 | $0.03 | $-0.05 | — | $0.06 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $357M | $314M | $345M | $299M | $332M | $304M | $277M | $307M |
| Inventory | $56M | $57M | $54M | $50M | $60M | $61M | $49M | $54M |
| Total current assets | $646M | $586M | $613M | $578M | $608M | $555M | $526M | $564M |
| Total assets | $3.31B | $3.24B | $3.26B | $3.19B | $3.22B | $3.10B | $3.07B | $3.15B |
| Long-term debt | $2.13B | $2.12B | $2.13B | $2.13B | $2.20B | $2.21B | $2.21B | $2.21B |
| Total liabilities | $2.64B | $2.61B | $2.66B | $2.64B | $2.71B | $2.68B | $2.67B | $2.68B |
| Total equity | $666M | $623M | $606M | $550M | $511M | $414M | $405M | $470M |